Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06535607
What this trial is testing

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca 257
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00003723
What this trial is testing

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)UnknownNCT01655888
What this trial is testing

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Testing effectiveness (Phase 2)Study completedNCT03654833
What this trial is testing

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University of Leicester 186
Testing effectiveness (Phase 2)Study completedNCT01358084
What this trial is testing

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

Who this might be right for
Advanced Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 137
Early research (Phase 1)Study completedNCT00003974
What this trial is testing

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Who this might be right for
Lung CancerMalignant Mesothelioma
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00272558
What this trial is testing

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00165516
What this trial is testing

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 85
Testing effectiveness (Phase 2)Study completedNCT00004033
What this trial is testing

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
NYU Langone Health 30
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Testing effectiveness (Phase 2)Study completedNCT00392444
What this trial is testing

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaRecurrent Malignant Mesothelioma
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)UnknownNCT00024271
What this trial is testing

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Who this might be right for
Malignant Mesothelioma
Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT00002465
What this trial is testing

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

Who this might be right for
Breast CancerEndometrial CancerMalignant Mesothelioma
St. Vincent Medical Center - Los Angeles
Testing effectiveness (Phase 2)Active Not RecruitingNCT02414269
What this trial is testing

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Who this might be right for
Malignant Pleural DiseaseMesotheliomaMetastases+2 more
Memorial Sloan Kettering Cancer Center 113
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT02716272
What this trial is testing

Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
Mesothelioma
Intergroupe Francophone de Cancerologie Thoracique 125
Next Page